Cytori Receives U.S. FDA Approval for Burn Clinical Trial Related to BARDA Contract
Apr 10, 2017 11:01 am UTC| Business
SAN DIEGO, April 10, 2017 -- Cytori Therapeutics, Inc. (NASDAQ:CYTX) today announced that the U.S. Food and Drug Administration (FDA) has approved an Investigational Device Exemption (IDE) for a pilot clinical trial to...
ClubCorp and Alexandria Real Estate Equities Launch New, Dynamic Club in Seattle
Apr 10, 2017 11:01 am UTC| Business
DALLAS, April 10, 2017 -- ClubCorp – The World Leader in Private Clubs® (NYSE:MYCC) – announces with Alexandria Real Estate Equities, Inc. (NYSE:ARE), the leader in collaborative life science and technology campuses,...
ClubCorp and Alexandria Real Estate Equities Launch New, Dynamic Club in Seattle
Apr 10, 2017 11:01 am UTC| Business
DALLAS, April 10, 2017 -- ClubCorp – The World Leader in Private Clubs® (NYSE:MYCC) – announces with Alexandria Real Estate Equities, Inc. (NYSE:ARE), the leader in collaborative life science and technology campuses,...
Uniti Group Inc. to Acquire Southern Light
Apr 10, 2017 11:00 am UTC| Business
Leading data transport provider across 5 states and 12 Southeast markets Expansive fiber network spanning over 540,000 fiber strand miles Uniti’s revenue diversification advances over key milestone to 30% away from...
Apr 10, 2017 11:00 am UTC| Business
DALLAS, April 10, 2017 -- ClubCorp – The World Leader in Private Clubs® (NYSE:MYCC) – today announced that it will release its first quarter fiscal 2017 financial results before market open on Wednesday, April 12,...
Mae Jemison, Ian Glazer and Larry Smarr Named Featured Speakers at Internet2’s 2017 Global Summit
Apr 10, 2017 11:00 am UTC| Business
Denver, Colo., April 10, 2017 -- Internet2, a member-driven advanced technology community founded by the nation’s leading higher education institutions, today confirmed three featured speakers at its 2017 Global Summit...
Apr 10, 2017 11:00 am UTC| Business
NEW YORK, April 10, 2017 -- Ovid Therapeutics, Inc., a privately held biopharmaceutical company committed to developing medicines that transform the lives of people with rare neurological diseases, today announced that...